Montelukast
Product Images NDC 0143-9651

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Montelukast (NDC 0143-9651). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by West Ward Pharmaceutical Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Monte Tab Alkem Figure 01)

A line graph depicting the change in height (cm) over weeks of treatment for three different groups: Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and a placebo. The X-axis represents weeks on treatment ranging from -19 to 56, and the Y-axis shows change in height from -3 to 7 cm. The graph compares growth effects among the three groups over time.*

FDA Label Image

Chemical Structure (Monte Tab Alkem Figure 02)

Chemical structure of Montelukast, depicting its molecular arrangement with component groups including a chlorinated bicyclic ring, a substituted phenyl ring, and additional functional groups including a cyclopropylacetate and a substituted hydroxybenzyl moiety.*

FDA Label Image

Figure 2 (Monte Tab Alkem Figure 03)

A line graph depicting the mean percent change from baseline over weeks of treatment for Montelukast versus placebo, including a washout phase. The x-axis represents weeks in treatment (0 to 15), and the y-axis represents mean percent change from baseline (0 to 15). Montelukast shows a steady increase in percent change compared to placebo throughout treatment, with data points marked by symbols and error bars.*

FDA Label Image

Montelukast Sodium Tablets, 10 mg (Monte Tab Alkem Figure 04)

Montelukast Sodium 10 mg tablets label showing the product name, strength, and dosage form. The label includes directions to dispense the patient information leaflet and states it is for adults 15 years and older. It lists West-Ward Pharmaceuticals as the labeler, with manufacturing by Unimark Remedies Ltd and Kemwell Biopharma Pvt. Ltd in India, and distribution by West-Ward Pharmaceutical Corp, Eatontown, NJ. The label also includes storage instructions and a barcode.*

FDA Label Image

Montelukast Sodium Chewable Tablets, 4 mg (Monte Tab Alkem Figure 05)

Montelukast Sodium 4 mg chewable tablets label by West-Ward Pharmaceuticals. The label notes 30 tablets per container, for pediatric patients aged 2-5 years. It includes dosage details, storage instructions, manufacturer Unimark Remedies Ltd., Kemwell Biopharma Pvt. Ltd. in India, and distribution by West-Ward Pharmaceutical Corp., Eatontown, NJ, USA.*

FDA Label Image

Montelukast Sodium Chewable Tablets, 5 mg (Monte Tab Alkem Figure 06)

Drug facts panel for Montelukast Sodium 5 mg chewable tablets. The panel details each tablet's content, phenylketonuric warning, usual dosage instructions, storage conditions, manufacturing and distribution information, and cautions for keeping medication out of children's reach. The product is distributed by West-Ward Pharmaceutical Corp.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.